Aims: To evaluate the efficacy and safety of mirabegron in males with overactive bladder (OAB) symptoms.
Methods: In total, 464 males with OAB symptoms were enrolled from 14 institutes and were sorted into either the mirabegron 50 mg (n = 310) or placebo (n = 154) groups. The change in (i) the mean number of 24-h micturition episodes; (ii) OAB Symptom Scale (OABSS); and (iii) International Prostate Symptom Score (IPSS) from baseline to 12 weeks of treatment were compared between the two groups. Safety assessments included treatment-emergent adverse events, blood pressure, pulse rate, postvoid residual volume, and maximum urinary flow rate. After 12 weeks, the study was extended for 14 additional weeks by administering mirabegron 50 mg to both groups.
Results: The reduction in the mean number of 24-h micturition episodes from baseline to 12 weeks of treatment was similar between the two groups. However, significantly greater changes from baseline to 12 weeks were observed in total OABSS, OABSS urgency incontinence score (Q4), IPSS storage subscore (Q2 + Q4 + Q7), and IPSS urgency score (Q4) in the mirabegron group (P = 0.01 for all). According to the extended study, the changes of all efficacy variables from baseline to 26 weeks were similar between both groups. The safety assessment results were also similar between the two groups at 12 and 26 weeks.
Conclusion: A daily 50 mg dose of mirabegron for 12 weeks reduced OAB symptoms in men, and no significant adverse events compared to the placebo group were noted.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/nau.23852 | DOI Listing |
Int J MCH AIDS
November 2024
Vanderbilt Institute for Global Health (VIGH), Vanderbilt University Medical Center (VUMC), Nashville, TN, United States.
Background And Objective: Sexual health research among women living with human immunodeficiency virus (HIV) has focused mainly on sexual practices and risk behaviors, with little consideration for treating sexual dysfunction and improving sexual satisfaction. The aim of this pilot study was to assess the effectiveness of an adaptive counseling care model in the management of female sexual dysfunction (FSD) among women living with HIV and without HIV in northern Nigeria.
Methods: This was a prospective cohort study of 200 women with HIV and a matched comparison arm of 200 women without HIV.
Front Pharmacol
December 2024
Department of Urology, School of Medicine, The Second Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
Background: HJIG is a potential treatment for erectile dysfunction (ED) that has been used in China for over 20 years. We conducted a multi-center, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of the Chinese Herbal Medicine, Hongjing I granule (HJIG), in patients with mild to moderate erectile dysfunction (ED).
Methods: This study is structured as a randomized, double-blind, placebo-controlled trial, executed across multiple centers.
Eur J Sport Sci
February 2025
School of Sport, University of Brighton, Brighton, UK.
Sleep hygiene can be defined as practicing habits that facilitate sleep; poor sleep hygiene is common among elite athletes, and improving this can be one way to enhance sleep indices. Given the large inter-individual variability of sleep, there is a need for further investigation into individualised sleep hygiene for elite female athletes, with consideration for the practical application of the method. Using a self-controlled time series design with repeated measures, n = 16 professional female footballers completed a 9-week study during mid-season.
View Article and Find Full Text PDFJ Bras Nefrol
January 2025
Universidade de Brasília, Faculdade de Ciências da Saúde, Brasília, DF, Brazil.
Introduction: Multicenter research initiatives in Brazilian dialysis centers are scarce. We described the recruitment and implementation phases of the SARC-HD study, aimed at investigating sarcopenia and its impact on adverse clinical outcomes.
Methods: The SARC-HD is a cohort study being conducted with patients on hemodialysis in Brazil.
Health Serv Res
January 2025
Department of Epidemiology and Population Health, Stanford University, Palo Alto, California, USA.
Objective: To assess mental health related outcomes of Recipe4Health, a multisectoral social care partnership implementing produce prescriptions with or without group medical visits (GMVs).
Study Setting And Design: Recipe4Health was implemented at five community health centers from 2020 to 2023. Primary care teams referred patients with food insecurity and/or nutrition-sensitive chronic conditions (e.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!